Tango Therapeutics (TNGX)
(Delayed Data from NSDQ)
$8.30 USD
-0.11 (-1.31%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $8.40 +0.10 (1.20%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.34 |
EPS Last Quarter | -0.24 |
Last EPS Surprise | 29.41% |
ABR | 1.00 |
Earnings ESP
|
6.80% |
---|---|
Current Year | -1.27 |
Next Year | -1.42 |
EPS (TTM) | -1.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.04M | 8.05M | 42.43M | 33.94M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 12.20M | 15.70M | 54.30M | 57.70M |
Low Estimate | 5.80M | 4.50M | 37.10M | 25.00M |
Year ago Sales | 10.73M | 5.43M | 36.53M | 42.43M |
Year over Year Growth Est. | -25.06% | 48.25% | 16.17% | -20.01% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.34 | -0.34 | -1.27 | -1.42 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.32 | -0.39 | -1.29 | -1.50 |
High Estimate | -0.30 | -0.26 | -1.13 | -1.01 |
Low Estimate | -0.38 | -0.39 | -1.35 | -1.61 |
Year ago EPS | -0.23 | -0.32 | -1.08 | -1.27 |
Year over Year Growth Est. | -47.83% | -6.25% | -17.59% | -11.61% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 3 | 4 | 5 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 3 | 2 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.34 | -0.34 | -1.27 | -1.42 |
7 Days Ago | -0.34 | -0.34 | -1.27 | -1.42 |
30 Days Ago | -0.35 | -0.35 | -1.31 | -1.42 |
60 Days Ago | -0.34 | -0.33 | -1.35 | -1.41 |
90 Days Ago | -0.33 | -0.31 | -1.31 | -1.35 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.32 | -0.39 | -1.29 | -1.50 |
Zacks Consensus Estimate | -0.34 | -0.34 | -1.27 | -1.42 |
Earnings ESP | 6.80% | -14.71% | -1.23% | -5.51% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.24 | -0.35 | -0.32 | -0.23 | NA |
Estimate | -0.34 | -0.31 | -0.28 | -0.34 | NA |
Difference | 0.10 | -0.04 | -0.04 | 0.11 | 0.03 |
Surprise | 29.41% | -12.90% | -14.29% | 32.35% | 8.64% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more